Clinical Trial Update: Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial [NA]

View source ↗

Summary

A first-in-human trial of a percutaneous phrenic nerve stimulator for diaphragm pacing has completed. Sponsor: Lungpacer Medical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-induced Lung Injury

Drugs mentioned

• Phrenic nerve stimulator (diaphragm pacing)

Snippet

Sponsor: Lungpacer Medical Inc. | Conditions: Ventilator Induced Lung Injury | NA | Status: COMPLETED